Ansaam Daoud, MD
- Specialty: Rheumatology
-
Location:UH Cleveland Medical Center Mather
11100 Euclid Ave
Cleveland, OH 44106
- Call: 216-844-2289
Biography: Ansaam Daoud, MD
Expertise
Certifications & Memberships
- Rheumatology - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
- Fellow, American College of Rheumatology (FACR)
- Member, SPARTAN (Spondyloarthritis Research and Treatment Network)
- Member, American College of Physicians
Education
Fellowship | Rheumatology
Rheumatology - UH Cleveland Medical Center (2022 - 2024)
Residency | Internal Medicine
Internal Medicine - Akron General Medical Center (2019 - 2022)
Medical Education
Jordan University Of Science And Technology (2015)
About
Ansaam Daoud, MD, is board-certified in Internal Medicine and Rheumatology and is a Fellow of the American College of Rheumatology (FACR). She serves as a rheumatologist at University Hospitals Cleveland Medical Center and Assistant Professor of Medicine at Case Western Reserve University School of Medicine.
Dr. Daoud completed her fellowship training in Rheumatology at University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine in Cleveland. During fellowship, she was honored with the Ali Askari Humanitarian Award, recognizing her compassionate care and dedication to patients. She completed her internal medicine residency at Cleveland Clinic Akron General.
Her clinical and research interests focus on diagnosis and treatment of autoimmune rheumatic diseases. She has published and presented extensively on mortality related to connective tissue diseases, systemic lupus erythematosus, and spondyloarthritis.
Research & Publications
Research Interests
Autoimmune rheumatic diseases, mortality related to connective tissue diseases, systemic lupus erythematosus, and spondyloarthritis
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Ansaam Daoud did not disclose any Outside Relationships with Industry.